Numeta G13%E Preterm for Nutritional Care (glucose solution, lipid emulsion, paediatric amino acids, electrolytes)

The information contained in this page is intended for UK healthcare professionals only.

Numeta G13%E Preterm is the only⁵ triple-chamber, licensed and terminally sterilised, ready-to-use parenteral nutrition product available to treat preterm infants who are at risk for malnutrition in the early hours and days of their lives.

Numeta G13%E Preterm is formulated to follow the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and The European Society of Clinical Nutrition and Metabolism (ESPEN)^1,2,3 guidelines to meet neonatal nutritional needs with a balanced formulation of amino acids (protein), glucose (carbohydrates), lipids (fats) and electrolytes.

Numeta G13%E Preterm is also available in additional formulations, including NUMETA G16%E 500mL for full term infants through two years of age, and NUMETA G19%E 1,000mL for children and adolescents (2-18 years of age).

Numeta G13%E Preterm is industrially prepared, lowering the risk of medication errors and infection associated with custom compounding⁴

Prescribing Information

Product Details

Flexible

Numeta G13%E Preterm is flexible to meet patient needs day by day

Activate the lipid chamber only as needed

Add other ingredients as needed

Ready

Available for immediate nutritional support, with stability to store at room temperature

Adverse Events and any drug or medical device product quality complaints (including suspected defective medicines or medical device adverse incidents) should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse Events should also be reported to Baxter Healthcare Ltd, by email ([email protected]) or by phone (+44 (0)1635 206360). Drug or medical device product quality complaints relating to Baxter products can be reported directly to Baxter Healthcare Ltd by email ([email protected]) or by phone (+44 (0) 1604 704603).

See References

Van Goudoever, J., Carnielli, V., Darmaun, D. and de Pipaon, M., 2018. ESPGHAN/ESPEN/ESPR guidelines on pediatric parenteral nutrition: Amino acids. Clinical Nutrition, pp.1-9.
Mesotten, D., Joosten, K., van Kempen, A. and Verbruggen, S., 2018. ESPGHAN/ESPEN/ESPR guidelines on pediatric parenteral nutrition: Carbohydrates. Clinical Nutrition, pp.1-7.
Jochum, F., Moltu, S., Senterre, T., Nomayo, A., Goulet, O. and Iacobelli, S., 2018. ESPGHAN/ESPEN/ESPR guidelines on pediatric parenteral nutrition: Fluid and electrolytes. Clinical Nutrition, pp.1-10.
Austin PD, Hand KS, Elia M. Systematic review and meta-analysis of the risk of microbial contamination of parenteral doses prepared under aseptic techniques in clinical and pharmaceutical environments: an update. J Hosp Infect 2015;91:306–318.
Baxter data on file; Licensed 3-chamber parenteral nutrition bags - 05/06/2023

Healthcare Professionals

Perspectives

Our Story

Patients

Numeta G13%E Preterm for Nutritional Care (glucose solution, lipid emulsion, paediatric amino acids, electrolytes)

Numeta G13%E Preterm is the only⁵ triple-chamber, licensed and terminally sterilised, ready-to-use parenteral nutrition product available to treat preterm infants who are at risk for malnutrition in the early hours and days of their lives.

Product Details

Adverse Event and Product Complaint Reporting

Numeta G13%E Preterm is the only5 triple-chamber, licensed and terminally sterilised, ready-to-use parenteral nutrition product available to treat preterm infants who are at risk for malnutrition in the early hours and days of their lives.

Product Details

Adverse Event and Product Complaint Reporting

Numeta G13%E Preterm is the only⁵ triple-chamber, licensed and terminally sterilised, ready-to-use parenteral nutrition product available to treat preterm infants who are at risk for malnutrition in the early hours and days of their lives.